A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis
Aishath Naeem(Harvard University), Ryan F.L. O’Shaughnessy(Queen Mary University of London)
Cited by 47
Related Papers
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
|Blood Advances|2022|79
AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation
|Cell Death and Differentiation|2015|72
Cutaneous Human Papillomaviruses Down-regulate AKT1, whereas AKT2 Up-regulation and Activation Associates with Tumors
|Cancer Research|2007|40
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples
|Blood|2023|26
Akt1-associated actomyosin remodelling is required for nuclear lamina dispersal and nuclear shrinkage in epidermal terminal differentiation
|Cell Death and Differentiation|2021|17